Reticuloendotheiosis viruses have been shown to be causative of tumors in a variety of avian species. The Avian RNA-containing tumor viruses include those that are causative agents of sarcomas and leukemias (8, 30) . These viruses are genetically related to endogenous type C retroviruses of avian cells (3, 29) . A more recently discovered group of retroviruses, the reticuloendotheliosis virus (REV) group (7, 22, 28, 32, 37, 38) , exhibits different morphology (26, 43) and lacks detectable shared antigenic determinants (23, 25, 28, 37) or nucleotide sequence homology with avian leukosis-sarcoma viruses (16). Moreover, it has been possible to demonstrate only limited physiological complementation between the two virus groups (40) .
In common with the avian and mammalian retroviruses, the REV group appears to contain both replication-defective acutely oncogenic viruses and less or non-oncogenic associated helper viruses (J. D. Hoelzer, R. B. Frankln, and H. R. Bose, Virology, in press). Much of the current biochemical and immunological studies have been carried out on these associated helper viruses. Several lines of evidence have suggested that the REV group may be related to mammalian type C retroviruses. Avian REVs have been reported to possess ultrastructural features that resemble those of mammalian type C retroviruses (26, 43) ; they possess an RNA-dependent DNA polymerase complex whose molecular weight and cation preference are similar to those of murine leukemia viruses (MuLV) (26) ; and, finally, recent experiments have shown striking amino acid sequence homologies at the amino termini of REV p30, Rauscher MuLV p30, and feline leukemia virus (FeLV) p30 (14) .
Radioimmunological approaches have been useful in establishing evolutionary linkage among isolates of the major groups of mammalian retroviruses (for a review, see reference 1).
In the present studies, we have applied these techniques to the analysis of viruses of the REV group in efforts to establish their evolutionary relationship to retroviruses of mammalian origin.
MATERIALS AND METHODS Cells and viruses. CeUs were grown in Dulbeccomodified Eagle medium supplemented with 10% calf serum (Colorado Serum Co., Denver, Colo.). The nontransforming associated helper virus from REV strain T (32, 37) , designated REV-A, was grown in avian (quail QT-6) and mammalian (dog sarcoma D17) cell lines. The other members of the REV group, including spleen necrosis virus (SNV) (38) , duck infectious anemia virus (DIAV) (22) , and chick syncytial virus (CSV) (7) were grown in chicken embryo cells. Viruses were purified from tissue culture fluids by isopycnic banding in linear sucrose gradients. The mammalian retroviruses utilized in the present studies have been described elsewhere (6) .
Antisera. Antisera were prepared by immunization of either goats or rabbits with Tween ether-disrupted viruses or purified viral proteins. Caprine antiserum directed against "p30 interspecies determinants" was prepared by sequential immunization with the major structural proteins of Rauscher MuLV, rat endogenous type C virus, simian sarcoma-associated virus, and REV-A p30 and p22 structural proteins were purified according to methods previously described for murine type C viral proteins (4) . Briefly, isopycnically banded virus (10 mg of total protein) was disrupted by the addition of 0.05 volume of 1 M Tris-hydrochloride buffer (pH 9.0) containing 20% Triton X-100. Nonsolubilized material was pelleted by centrifugation (100,000 x g) for 20 min and suspended in 0.2 volume of 50 mM Tris-hydrochloride buffer (pH 9.0) containing 1% Triton X-100. Solubilized proteins were pooled and extensively dialyzed against a 10 mM BES [N,Nbis -(2 -hydroxyethyl) -2 -aminoethanesulfonic acid] buffer (pH 6.5) containing 0.1 mM EDTA and 0.5% Triton X-100 (BET buffer), until the pH and conductivity of the sample equaled those of the buffer. The dialyzed sample was applied to a phosphocellulose column (1.0 by 5.0 cm) (Whatman, Pll), previously equilibrated with BET buffer. Bound proteins were eluted with 100 ml of a 0.0 to 1.0 M KCl linear gradient in BET buffer.
Analysis of 0.1-ml aliquots of the gradient fractions (1.5 ml) by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis revealed the presence of homogeneous REV-A p22 in gradient fractions containing 150 to 200 mM KCl. Higher KCl concentrations (350 to 400 mM) were needed to elute REV-A p30 from the phosphocellulose column. After concentration by ultrafiltration, REV-A p30 was further purified by acrylamide-agarose gel filtration (Ultrogel Aca 44 LKB), utilizing a column (1.5 by 90 cm) equilibrated with a 20 mM Tris-hydrochloride buffer (pH 7.8) containing 0.1 mM EDTA, 100 mM KCl, and 0.2% Triton X-100. Homogeneous REV-A p30, as determined by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis analysis, was found to elute at a position corresponding to an apparent molecular weight of 30,000.
For radioimmunological studies, purified REV-A p30 and p22 proteins (1 to 3 ug) were labeled to high specific activity with "I by the chloramine T method (12) . The labeling reaction was initiated by the addition of 0.2 ,ug of chloramine T in 0.01 ml of distilled water. After 1 min of incubation at room temperature, the reaction was terminated by the addition of 0.5 ug of sodium metabisulfite. The l"I-labeled protein was separated from "nI-labeled Triton X-100 and free iodine-125 by gel filtration (P-10, 50 to 100 mesh, BioRad) in a column (0.3 by 10 cm) equilibrated with 20 mM Tris-hydrochloride (pH 7.8), 200 mM NaCl, and 1 mM EDTA buffer. The purity of the radioactive probes was higher than 90% as determined by both electrophoretic and immunological criteria.
Radioimmunoassays. Double-antibody precipitation and competition radioimmunoassays were performed as previously described (13) . Briefly, twofold serial dilutions of the appropriate antisera were incubated for 3 h at 37°C with 10,000 cpm of the 25I-labeled antigen in a 0.2-ml reaction mixture containing 10 mM Tris-hydrochloride (pH 7.8), 20 mM NaCl, 1 mM EDTA, 0.4% Triton X-100, and 0.6% bovine serum albumin. After incubation at 40C for 18 h, 0.025 ml of undiluted swine anti-goat or anti-rabbit immunoglobulin G was added and incubated for another 3 h at 4°C. Samples, diluted to 1 ml with the same buffer except for the omission of bovine serum albumin, were centrifuged at 2,500 rpm for 15 min. Supernatants were aspirated, and the radioactivity in the precipitate was measured in a Searle 1285 gamma counter.
Competition radioimmunoassays were performed similarly except that twofold serial dilutions of the competing antigen were preincubated for 1 h at 37°C with a limiting antiserum dilution able to precipitate 25% of the input "25I-labeled antigen. Protein concentrations were determined as described by Lowry et al. (21) 
RESULTS
Immunological relatedness among the REV group of avian retroviruses. To date, four independent isolates form the REV group of infectious avian retroviruses (28) . They include the oncogenic T strain of REV (32, 37), which has recently been shown to be a mixture of replication-defective transforming virus (REV) and nontransforming helper virus (REV-A) (Hoelzer et al., in press), SNV (38) , DIAV (22) , and the as yet nonpathogenic CSV (7, 41) . These viruses are known to share extensive nucleotide homologies (16) and to possess a common group-specific antigen (24) . In the present studies, we have utilized radioimmunological techniques to analyze the degree of relatedness among these viruses by quantitating the presence of type-specific antigenic determinants in their translational products.
The major structural protein of REV-A was purified to homogeneity by sequential phosphocellulose and gel filtration chromatography. A homologous immunoassay utilizing limiting anti-REV-A serum to bind l"I-labeled REV-A p30 was developed. Detergent-disrupted REV-A either grown in quail (QT-6) or canine (D17) cells competed completely in this assay (Fig.  1A) , thus demonstrating the virus-coded nature of this protein. The other members of this virus group, including CSV, SNV, and DIAV, exhibited very similar, if not identical, competition curves. These results indicated a very high degree of antigenic relatedness among the major structural proteins of the REV group.
Previous studies have demonstrated that certain low-molecular-weight proteins of avian and mammalian type C viruses possess pronounced type-specific determinants, making them very useful as markers to distinguish otherwise closely related virus strains (34, 36, 39) . Thus, we purified and developed an homologous radioimmunoassay for the p22 structural protein of REV-A. Detergent-disrupted REV-A, but not SNV, CSV, or DIAV, was capable of completely displacing the "251-labeled probe when tested as a competing antigen in the REV p22 radioimmunoassay (Fig. 1B) . These results demon-VOL. 30, 1979 on strated the presence of type-specific determinants in this REV-A low-molecular-weight protein, making it possible to distingusih REV-A from other members of the REV group.
The major structural proteins of REV-A and mammalian type C viruses share antigenic determinants. The reverse transcriptase of REV-A is known to bear structural and functional analogies to those ofmurine type C viruses (26) . More recently, amino acid sequence homologies between REV-A and lian type C viral p30's have been demonstrated (14) . These findings have led to the proposal that REV may have a mmmian rather than avian origin (14, 26) . It has been possible to demonstrate immunological relatedness among several ofthe respective translational products ofknown mammalian type C viruses (5, 10, 11, 19, 33, 35) . These findings have strongly supported the hypothesis that manmmlian type C viruses are evolutionarily related and thus arose from a common progenitor (1) . We reasoned that demonstration of antigenic determinants shared between REV structural proteins and those of any of the well-characterized mammalian retroviruses should provide further evidence for a mammalian origin of the REV group.
Both rabbit and goat antisera raised against detergent-disrupted REV-A precipitated the "MI-labeled major structural proteins of two mammalian type C viruses, both of which are of rodent origin ( raised against each of several purified mouse type C proteins were tested (data not shown). Avian REV and mammalian type C retroviruses are evolutionarily related. The specificity of the above findings was next investigated by developing appropriate double-antibody competition radioimmunoassays. A large variety of detergent-disrupted retroviruses were tested for their ability to displace limiting amounts of anti-Rauscher MuLV p30 serum from binding 125I-labeled REV-A p30. REV-A, as well as exogenous and endogenous type C viral isolates of Mus musculus, was able to displace the radioactive probe completely (Fig. 2) . Extensive, although not complete, cross-reactivity was observed with other tested mammalian type C viruses. These included endogenous viruses of Mus caroli (MCH-T), rat, mink, cat (RD114), deer, and baboon, as well as non-genetically transmitted viruses of cats (FeLV) and certain primates, including woolly monkey and gibbon ape.
The above results indicated that most of the antigenic determinants shared by REV-A and Rauscher MuLV p30's were present in all of the mammalian type C retroviruses tested. In contrast, the same assays revealed no evidence of immunological cross-reactivity of avian type C (avian myeloblastosis virus [AMV] Fig. 2 ).
These results, taken together, establish the specificity of the evolutionary linkage between REV-A and mammalian type C viruses.
We next extended these studies to the other members of the REV group. SNV, CSV, and DIAV exhibited complete competition curves when tested as competing antigens in the antiRauscher MuLV p30-251I-labeled REV p30 assay (Fig. 3) . These findings, along with the established immunological relationships between this group of viruses, strongly suggest that the REV group of infectious agents are derived from a mammalian type C viral progenitor.
Origin of the avian REV group. We next investigated whether subsets of antigenic determinants shared by REV-A p30 and closely related groups of mammalian type C viruses might make it possible to more precisely define the origin of the REV group. Interspecies radioimmunoassays capable of detecting p30 determinants shared by rodent and feline viruses (antiFeLV-'25I-labeled Rauscher MuLV p30) or primate endogenous virus (anti-P. cynocephalus baboon virus-'25I-labeled RD114 p30) were utilized. REV-A p30 did not exhibit any of these antigenic determinants, as determined by the failure of REV-A to compete in these interspecies assays (Fig. 4) . Recently, broadly reactive immunoassays capable of detecting all known mammalian type C viruses have been described (6) . These include competition assays in which limiting amounts of either high-titered anti-Rauscher MuLV p30 serum or a caprine anti-p30 interspecies determinants serum, prepared by sequential immunization with several purified type C viral p30's, were used to bind '25I-labeled RD114 p30. REV-A was able to displace around 50% of the '25I-labeled RD114 p30 in either assay (Fig. 4) . Similar results were obtained with SNV, CSV, and DIAV (data not shown). The sensitivity of REV-A detection in the interspecies immunoassays, as compared to that observed in the REV-A p30 homologous assay, suggested that these broadly reactive interspecies determinants represent no more than 1% of the total antigenic capacity of the REV-A p30 molecule. These results firmly establish major structural proteins of the REV group as mammalian type C virus in origin. However, they do not make it possible to assign any of the well-characterized mammalian type C viral isolates as the direct progenitor of the avian REV group. DISCUSSION Type C retroviruses of vertebrates include those that are genetically transmitted within their host and those transmitted by a more classical route as infectious agents. To date, endogenous type C viruses have been shown to be oncogenic only under conditions in which there is poor host cell control of virus expression (for review, see reference 2). Similarly, horizontally transmitted retroviruses are generally tumorigenic in hosts susceptible to active virus replication. Infectious type C viruses have been shown to be causative of naturally occurring tumors in birds, rodents, carnivores, and primates (8, 9, 15, 18, 30) .
Two major groups of infectious type C retroviruses have been isolated from avian species. Exogenous retroviruses that induce leukosis and sarcomas (8, 30) demonstrate partial nucleotide sequence homology with endogenous avian type C viruses (3, 29) . A more recently described avian retrovirus group is causative of reticuloendotheliosis and related diseases (28) . In contrast to the avian leukosis-sarcoma virus group, REVs share no genetic homology with cellular DNA of their natural hosts (17) . Moreover, attempts to detect evidence of nucleotide sequence or antigenic homology between avian leukosissarcoma viruses and members of the REV group have been unsuccessful (16, 23, 28, 37) . Radioimmunological techniques have made it possible to demonstrate antigenic determinants shared among several of the respective translational products of known mammalian type C retroviruses (5, 10, 11, 19, 33, 35) . These findings have strongly implied a common progenitor in the evolution of these viruses (1) . In the present studies, broadly reactive immunoassays were used to establish the origin of viruses of the REV group. We were able to show that antigenic determinants common to the major structural proteins of all known mammalian type C viruses were shared by the major structural protein p30 of the REV. Moreover, antisera directed against REV-A specifically recognized antigenic determinants of two mammalian type C viral p30's.
All of these findings demonstrate the evolutionary linkage of viruses of the REV group to mammalian type C retroviruses.
Many non-genetically transmitted type C retroviruses have been shown to possess partial nucleotide sequence homology with the genome of their natural host. These findings have suggested that such exogenous viruses may have arisen from endogenous viruses that at one time escaped regulatory controls. Alternatively, a common infectious progenitor type C virus may have led to divergent lines, one of which became genetically associated with the cell, while the other persisted as an exogenous virus. In addition to the REV group, there are only a few examples of infectious type C retroviruses that exhibit no detectable genetic homology with cellular DNA of their natural host. The gibbon ape leukemia viruses represent one such infectious virus group (31) . Evidence has accumulated that these viruses are, however, related to endogenous viruses of Asian mice, suggesting that an endogenous murine retrovirus may be the progenitor of this group of oncogenic primate type C retroviruses (20, 42) .
Although the present studies establish by immunological criteria the evolutionary linkage of members of the REV group to mammalian type C viruses, it was not possible to demonstrate a closer antigenic relationship of REV and any particular mammalian type C virus subgroup. Two theories could explain these results. Since present members of the REV group are very closely related to one another, they may represent recent variants of a single virus, whose mammalian type C viral ancestor has been transmitted as an infectious virus for a long period of evolution. Altematively, the REV group may have arisen by a relatively recent infection of birds with an as yet undiscovered endogenous mammalian type C retrovirus. This latter possibility suggests that the continued search for a mammalian species, whose genome exhibits extensive nucleotide sequence homology with REV, is warranted. The present development of immunoassays involving REV-A p30 and capable of detecting known mammalian type C viruses, including the REV group, should help in the search for such as REV-related endogenous mammalian type C retrovirus.
